On Holding and Kylian Mbappé: The Bet to Buy Credibility in Football Boots

On Holding and Kylian Mbappé: The Bet to Buy Credibility in Football Boots

There was a match I refereed badly, and from it I learned what fairness means. I carried that principle from the pitch to the desk: when people celebrate a deal, the referee's job is to read the report before blowing the final whistle. This week, that report came from Zurich and Paris, not from any stand.

On August 13, 2026, Reuters reported that On Holding AG — the Swiss sportswear brand built on running shoes — announced an endorsement partnership with Kylian Mbappé. Immediately, On's share price slipped 0.3% in choppy trading. A number so small I had to check twice whether I had misread the decimal. But precisely because it is small, it deserves attention.

I sat in front of the screen at 2 a.m. London time, the shift I have kept for years to track European sports-business news. The crowdless season taught me one thing: with only the steady hum of cameras, I began hearing the whisper of technology in every number. Tonight, that whisper came from a balance sheet.

Context: When Running Shoes Step onto Grass

To understand why this deal matters, we must step back to On's trajectory. This was never a football brand. On built its reputation in high-performance running, with distinctive cushioning and a proprietary manufacturing technology called LightSpray — a robotic system that sprays material directly onto the shoe upper, minimizing stitching and optimizing weight.

On's symbolic turning point came in 2026, when Roger Federer left Nike to join the Swiss brand. According to Forbes, Federer received roughly 2.5% equity in that deal. It was not an ordinary endorsement, but a hybrid structure blending brand ambassador and shareholder. From there, On entered tennis. Now, On enters football.

Three phases, one logic: running, tennis, football. In the industry, this is called "adjacency stacking" — expanding from a core category into adjacent ones to sustain growth. Each jump into a new category raises the marketing-cost bar and lifts the technical barrier a tier higher.

I have watched this model long enough to know it is not for the impatient. People watch matches with their hearts; I watch with lines already drawn. On's lines are drawn by a single question: can a running brand buy credibility on the pitch without ten years of wear-testing at academies?

To answer, On chose two moves at once. First, signing Kylian Mbappé — a star at his peak, mid-twenties, meaning years before the end of his commercial prime. Second, appointing Thierry Henry as director of the soccer business. Henry is not a purely marketing name; he has networks across players, coaches, and European academies.

On's task, therefore, is not just advertising. It is an organizational bet: building institutional football capability, not just running a campaign.

Core Analysis: Which Numbers Tell the Truth

Now the hardest part, the part I spend the most time on before every broadcast: reading data without letting it read me back.

Three data sets appear in the Reuters report.

First, market-share data. M Science — a consumer-data tracker — recorded that On gained share in the three months to August 2026, while Nike kept losing it. According to Reuters, On lifted its share while Nike showed a stalled turnaround.

Second, valuation data. On trades at a price-to-earnings (P/E) ratio of 18.7x, slightly above sportswear rivals. This "slightly above" is the pivot of much debate. It means the market prices On as a high-growth company, not a stable one.

Third, regional revenue data. More than 50% of On's revenue comes from the Americas. And per the article, this is precisely the region flagged as declining. This is the point I want to bold: the Mbappé deal must win in the very market where the brand is weakest — the Americas — not in Europe or Asia, where football is more popular but the revenue base is smaller.

These three data points together give a picture that is anything but linear. On has momentum at the share level, but that momentum is not converting into investor optimism. The stock fell 0.3%, within normal daily noise. But as a signal, it says more than a single number.

Analyst Randy Konik of Jefferies offered a notable argument: performance credibility cannot simply be bought. He argued On needs to spend harder to sustain growth. This is a technically flavored claim, not a purely financial one. Konik is talking about what I call the "match-report certificate" in the boot industry: a boot is only recognized when elite players wear it and perform well on the pitch, before millions of eyes.

The article also cites a named cautionary case: Under Armour and Stephen Curry. This is the classic example of a brand signing a top-tier athlete, building a product line named after him, yet not becoming an industry giant because of it. Curry is one of the greatest basketball players in history, but Under Armour did not thereby topple Nike. The question for On is: why would Mbappé be different from Curry?

Defenders of the deal have their arguments. On has LightSpray technology, cited as a potential asset for entering the football boot segment. This is a manufacturing argument, not a playing-style one. But I must be blunt: LightSpray's transferability from a running-shoe upper to a football boot is unproven. A football boot must withstand kicking, wet-grass traction loads, and entirely different biomechanics. What works on the track does not automatically work on grass.

This is where I record a principle I learned from refereeing: when you lack data, do not pretend you have it. On did not disclose the deal value. A company spokesperson declined to disclose financial terms. But one detail is confirmed: the payment structure includes both cash and equity.

This is not new for On. Federer received roughly 2.5% equity in 2026. Paying in stock rather than cash preserves cash short-term but dilutes existing shareholders and ties the athlete's payout to the share price. It is a double-edged sword. On one hand, it incentivizes Mbappé to care about the brand's business performance. On the other, it pushes the true cost of the deal into the future as dilution — a latent liability not clearly visible on the balance sheet.

I built a 27-criteria checklist for every broadcast, and it always includes a blank box for "missing data." For this deal, that blank box is larger than in almost any case I have seen. No deal value, no term length, no activation budget, no EBITDA impact. Every ROI claim is currently speculative.

Morningstar analyst David Swartz asked directly: is the deal worth the cost? That is exactly the right question, and exactly the question the article cannot answer because there is no cost data. A right question without an answer is worth more than a wrong answer that looks certain.

Contrarian Angle: When the Market's Verdict Is Just Noise

This is the section I want to use for self-challenge, because in this profession, whoever cannot doubt themselves is the most dangerous.

The Reuters article implies that On's 0.3% dip shows investors are "not sold" on the story. I am not sure that is right. In 2026, the football world turned upside down, and I learned to stand still and observe amid the storm. The lesson from Germany's loss to South Korea in Kazan was: one moment does not make a trend. A shot hitting the post does not prove a team played well or badly; it only proves the ball flew a few centimeters off.

Applied here: a 0.3% move in a choppy session is within normal noise. It could reflect "sell the news" behavior — investors taking profit after the announcement — rather than a rejection of the investment thesis. Over-reading a small number is a mistake I once made in my career: offering a plausible explanation for an event that actually had nothing to explain.

But one difference stands out: the analysts cited all come from large institutions like Jefferies, Morningstar, and Columbia Threadneedle. They are not talking about Mbappé's playing ability. They are talking about capital allocation. This signals that professional investors see this deal entirely differently from how sports media sees it.

There is a paradox I want to make clear. In sports consumer goods, "performance credibility" and "brand awareness" are two different things. Brand awareness can be bought with advertising. Performance credibility must be built through testing, failure, correction, and re-testing — a process I still call "defensive standardization of error." No star shortens that time. Mbappé can put On's name on a Champions League billboard, but he cannot replace a boot model that must endure forty matches in a season.

In 2026, I misread Harry Kane's name three times on radio during an Arsenal-Tottenham match. I watched the entire tape overnight and realized I lacked knowledge of FIFA's new offside rule. I built a 27-criteria checklist and noted every player on both teams for three months. That lesson applies here intact: a brand cannot shorten learning time by signing a big name. It can only shorten learning time by learning faster.

And there is another layer rarely mentioned. Equity structures in endorsement deals raise transparency questions. When a listed company pays an athlete in stock, how the payment is valued, on what basis, and when dilution appears — all are questions investors may raise later, when specific figures appear in financial statements. For a deal like On-Mbappé, the initial lack of transparency itself creates an information gap that sustains skepticism.

I want to be honest about the limits of this perspective. I once analyzed a counterattack situation from motion data, only to realize later there was a camera angle I had not seen. Motion data does not tell me what a player thinks before a pass. Likewise, financial data does not tell me what On committed to in the contract, or whether any clause obliges Mbappé to wear the brand's boots in official matches. This is a blind spot I must acknowledge.

The Other Side: The Nike Story

People watch matches with their hearts; I watch with lines already drawn. One such line: in every deal like this, there are winners and there are those placed under pressure. The one under pressure here is named Nike.

The article frames On's move as "further trouble for Nike." That reading has basis, because M Science data shows market-share trends in the three months to August 2026 moving in opposite directions: On up, Nike down. But I want to test this trend with a longer measure.

In the football boot industry, Nike remains the dominant force built over decades. It has a network of academy contracts, presence in every competition from youth to professional, and a store of boot-craft knowledge no new brand can replicate in a few seasons. That advantage was built with time and can only be broken by time.

On is the hunter, not the hunted, in this specific deal. That reverses the usual direction of talent flow. But this is also the moment to look at industry cost structure. If On succeeds with Mbappé, it could push the price of top footballer endorsements industry-wide. And if prices rise, the cost to stay in the game rises for everyone, including On in its next deals. This is what I call "industry-wide cost inflation" — a trap an opening mover rarely considers.

If Nike responds by escalating sports spending defensively, On's cost to compete rises further. In a spending war, the side with the larger balance sheet usually endures longer. This is a structural risk no single star can erase.

About Kylian Mbappé, Thierry Henry, and the Commercial Squad Structure

A penalty can change a match's fate; a contract can change a club's fate. For On, Mbappé is that penalty. But I want to talk about the structure around him, not just him.

Mbappé is at his peak, mid-twenties. At that age, he is a multi-year commercial asset, not a short-term one. That means an equity-linked deal could accompany On through several stages of brand development. But it also puts On in a position of dependence on one individual — something my risk checklist always flags red: single-point dependency risk.

Thierry Henry, as director of the soccer business, is the more institutional move. This signals On wants to build long-term football capability, not just run a campaign. Henry has networks in the game, and those networks could be used to expand the roster of represented players — a "roster play" rather than a single deal.

But here I must be cautious. Signing a famous coach does not automatically create a product-development department. Signing a star does not automatically create an athlete-scouting function. Signing both does not automatically create infrastructure from academy to professional pitch. The biggest organizational risk is confusing campaign with capability. A campaign can be bought in a day. Capability takes years.

The head referee is not one who never errs; what matters is what he does after erring. For On, the question is not whether this deal is wrong — the deal is signed. The question is what On builds next.

Macro Context and Consumer Pressure

One factor the Reuters article mentions but I want to dig into is the economic backdrop. Shoppers face inflation and an uncertain economic environment. This is a headwind, and it matters more than it appears.

Football boots are not essential goods for most ordinary consumers. It is a product a budget-constrained buyer will consider deferring. In an inflationary environment, spending on general sports equipment is often among the first cut, after major items like housing and food. That means On is trying to expand a new product category just as consumer wallets tighten.

Combined with Americas revenue exceeding half of total and flagged as declining, we have an uncomfortable picture. Investors are not only assessing whether On can conquer football. They are assessing whether On can conquer football in its hardest market, at the most frugal consumer moment.

Synthesis: Risk Structure and Value Framework

To systematize, I lay out a framework here, using the simplest method I use for professional interviews.

Commercially, the biggest risk is that soccer-category ROI is unproven, with deal cost undisclosed. Level: high. Likelihood: medium. Impact: high. Mitigation: set measurable KPIs for boot sales and brand lift.

Geographically, revenue concentration in the Americas above 50%, with the region declining. Level: high. Likelihood: medium. Impact: high. Mitigation: diversify geography, defend the US market.

Competitively, entrenched incumbents in football boots. Level: high. Likelihood: high. Impact: medium. Mitigation: differentiate via LightSpray tech and roster.

On valuation, P/E above peers reflects high growth expectations priced in. Level: medium. Likelihood: medium. Impact: high. Mitigation: deliver consistent top-line growth.

On narrative, the "can't buy credibility" skepticism from Konik and the Under Armour-Curry example. Level: medium. Likelihood: medium. Impact: medium. Mitigation: validate product performance on pitch.

Overall, the risk level sits at medium-to-high. The basis is a category-entry bet with undisclosed cost, a revenue concentration flagged as weak, and a valuation pricing in continued high growth — all set against genuinely positive share momentum.

Every argument in the stands, off the pitch, has its answer in some camera angle. For this deal, the camera angle we need is next quarter's financial report. That is where soccer-category revenue will appear, or will not. That is where dilution from the equity structure will show, or be handled deftly. That is where Americas performance will surface.

Looking Ahead: What to Track

I do not make a habit of ending analysis with a prediction. I make a habit of ending with a list of things to track, because judgments can be wrong, but a tracking process can be verified.

First, soccer-category revenue signals in On's next quarterly report. If it exceeds overall market growth, the deal begins to be validated. If it lags or is not disclosed separately, skepticism is confirmed.

Second, Americas performance in regional disclosures. If the decline continues, it is the core risk to the thesis. If it stabilizes, recovery is forming.

Third, Nike's response in sports marketing. If Nike escalates endorsements or price competition, On's cost to compete rises — a variable On does not control.

Fourth, equity disclosures in regulatory filings. If there is significant dilution or performance-based earnouts, investor reaction will be notable.

Fifth, on-pitch boot performance validation. If elite players wear On boots in big matches, this is a sign performance credibility is being built. If not, the deal stops at advertising.

Stepping out alone with the whistle, sitting before the screen with a straight angle, in the end I am still the one in the middle of the vortex. This time, the vortex is not at the center of the pitch, but at the intersection of a running shoe, a football star, and a balance sheet. And as always, the referee is not permitted to blow the whistle in time with the crowd.

What I want to leave is not a verdict on this deal — the verdict lacks sufficient data, and I will not pretend otherwise. What I want to leave is a question the sports industry must answer in the coming years: can a brand shorten its learning time by paying in equity, or is learning time the one thing that cannot be bought? If the answer is no, then every investment in a star is merely a way of deferring the real investment — the investment in itself.